Loading stock…

New China Life Insurance Company Ltd. (601336) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

New China Life Insurance Company Ltd.

601336Market cap $23BPrice $8.4

Country🇨🇳China

SectorFinancials

IndustryInsurance

Sells life insurance, health coverage, and annuities to millions across China, investing massive premium reserves in bonds and equities. It's one of China's largest life insurers, backed indirectly by state-linked shareholders and a distribution army of career agents.

In Bastion Portfolios?

52W Return-9%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+4%5

Revenue Forecast

Rev CAGR (1y)-27%1

Rev CAGR (3y)-6%1

Rev CAGR (5y)-2%1

Earnings Forecast

EPS Growth Y+1+11%7

EPS Growth Y+2+3%5

EPS Growth Y+3+1%4

Quality

Margins

EBIT Margin60%10

Net Income Margin53%10

Free Cash Flow Margin129%10

Debt

Net Debt/EBITDA2.63

Efficiency

ROE43%10

ROA2%4

Earnings Stability88

GEAR+STRONG77

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)410

P/E Ratio (Forward 3y)410

P/BV1.39

EV Multiples

EV/EBITDA Fwd010

EV/EBIT Fwd010

Yield

Free Cash Flow Yield0.0%10

Dividend Yieldna–

Momentum

Short term

1 month return-6%4

3 month return-7%4

YTD return-17%3

Mid term

Price vs 52wHigh68%3

1 year return-5%4

Long term

3 year return+72%7

5 year return+61%6

Risk Shield

Price Risk

Beta0.58

Volatility35%6

Free Cash Flow

Free Cash Flow Margin129%10

Free Cash Flow Yield0.0%10

Quality

ROCE3%4

Earnings Stability88

Net Debt/EBITDA2.63

02Growth

Is it actually growing, and how fast?

601336New China Life Insurance Company

Revenue FY25$10.7B

GROWTH RATING↗

VERY WEAK5 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y-27%1

Revenue, next 3Y, CAGR-6%1

Revenue, next 5Y, CAGR-2%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+11%7

EPS growth, FY27E+3%5

EPS growth, FY28E+1%4

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 3%/yr vs revenue -6%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 95% of companies worldwide.

Revenue is set to shrink 6%/yr over the next 3 years, behind most of the market.1/10

Revenue grew 4%/yr over the last 3 years, but it is set to shrink 6%/yr from here.

Over five years revenue is set to shrink 2%/yr, behind 90% of companies worldwide.1/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business heading into decline. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

601336New China Life Insurance Company

Total return Current70.2%

Price return Current33.9%

MOMENTUM RATING↗

WEAK32 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-7%4

YTD return-17%3

MID & LONG-TERM▾SCORE

% of 52-week high68%3

1-year return-5%4

3-year return+72%7

5-year return+61%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +72% over three years and +61% over five, ahead of 60% of the market.

WATCH

Returns sit at the market level over the past month (-6%) and over three months (-7%).

WEAKNESSES

It's down 5% over the past year, now 32% below its 52-week high. That is a touch behind the market.

The stock is underperforming so far this year (-17%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on New China Life. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

601336New China Life Insurance Company

Revenue FY25$10.7B

GROWTH RATING↗

VERY WEAK5 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y-27%1

Revenue, next 3Y, CAGR-6%1

Revenue, next 5Y, CAGR-2%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+11%7

EPS growth, FY27E+3%5

EPS growth, FY28E+1%4

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 3%/yr vs revenue -6%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

Growth is the weak spot here, trailing 95% of companies worldwide.

Revenue is set to shrink 6%/yr over the next 3 years, behind most of the market.1/10

Revenue grew 4%/yr over the last 3 years, but it is set to shrink 6%/yr from here.

Over five years revenue is set to shrink 2%/yr, behind 90% of companies worldwide.1/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business heading into decline. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

601336New China Life Insurance Company

Total return Current70.2%

Price return Current33.9%

MOMENTUM RATING↗

WEAK32 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-7%4

YTD return-17%3

MID & LONG-TERM▾SCORE

% of 52-week high68%3

1-year return-5%4

3-year return+72%7

5-year return+61%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +72% over three years and +61% over five, ahead of 60% of the market.

WATCH

Returns sit at the market level over the past month (-6%) and over three months (-7%).

WEAKNESSES

It's down 5% over the past year, now 32% below its 52-week high. That is a touch behind the market.

The stock is underperforming so far this year (-17%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on New China Life. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community